Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03159546 · ClinicalTrials.gov registry record
FreeStyle Libre Flash Glucose Monitoring System Accuracy
A clinical trial of Diabete Mellitus, sponsored by Abbott Diabetes Care.
- Completed
- Registry status
- 50
- Enrollment target
- 4
- Study locations
NCT03159546: Completed study of Diabete Mellitus, sponsored by Abbott Diabetes Care.
NCT03159546 is a study of Diabete Mellitus that has completed, run by Abbott Diabetes Care. The registered enrollment target is 50 participants, below the 200-participant average among 6 other Diabete Mellitus trials with a reported enrollment target (75% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03159546, a study of Diabete Mellitus, has completed, sponsored by Abbott Diabetes Care.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
- 4
- Study locations
Study Summary
This is a non-randomized, single arm, multi-center, prospective, non-significant risk study to evaluate the FreeStyle Libre Flash Glucose Monitoring System.
Primary Outcome
System performance will be characterized with respect to YSI reference venous plasma sample measurements.
Conditions Studied
Interventions
- DEVICE Device: FreeStyle Libre Flash Glucose Monitoring System
Study Locations (4)
California
- William Sansum Diabetes Center - Santa Barbara
- Diablo Clinical Research - Walnut Creek
Idaho
- Rocky Mountain Diabetes & Osteoporosis Center - Idaho Falls
Washington
- Rainier Clinical Research Center - Renton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2017-05-13 |
| Est. Completion | 2017-08-24 |
What the finished NCT03159546 record still lists
NCT03159546 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 200-participant average among 6 other Diabete Mellitus trials with a reported enrollment target (75% lower).
The record links to 1 condition, with Diabete Mellitus appearing as the primary indexed condition, and to 1 intervention - of which Device: FreeStyle Libre Flash Glucose Monitoring System is the first listed.
NCT03159546 reports a single indexed study location in California, Idaho, Washington.
Frequently Asked Questions
What is clinical trial NCT03159546 about?
NCT03159546 is a clinical study titled "FreeStyle Libre Flash Glucose Monitoring System Accuracy". This is a non-randomized, single arm, multi-center, prospective, non-significant risk study to evaluate the FreeStyle Libre Flash Glucose Monitoring System.
What is the current status of trial NCT03159546?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2017-05-13. Estimated completion is 2017-08-24.
What conditions does trial NCT03159546 study?
This clinical trial studies the following conditions: Diabete Mellitus.
What interventions are being tested in trial NCT03159546?
The interventions under investigation include: Device: FreeStyle Libre Flash Glucose Monitoring System (DEVICE).
Who is sponsoring clinical trial NCT03159546?
This trial is sponsored by Abbott Diabetes Care, which has 26 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03159546 being conducted?
This trial has 4 study locations across California, Idaho, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabete Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Gemini Study: A Prospective, Multicenter Evaluation of Performance and Safety of the Eversense Gemini System With Flash Glucose Measurement Feature
RECRUITING · NA
-
FSL2 Post Approval Study for Pediatric and Young Adults Patients
RECRUITING
-
Efficacy of Placental Membrane Dressings in Accelerating Diabetic Foot Healing
RECRUITING · Phase 4
-
An Observational Pilot Study to Develop a Behavioral Economics Electronic Health Record Module to Guide the Care of Older Adults With Diabetes
COMPLETED
-
StatStrip A Glucose/Creatinine Meter System Lay User Study Evaluation
COMPLETED
-
Study of an Interstitial Fluid Glucose Sensor
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI